159 related articles for article (PubMed ID: 32436951)
21. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
[TBL] [Abstract][Full Text] [Related]
22. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
Hammer GD; Tyrrell JB; Lamborn KR; Applebury CB; Hannegan ET; Bell S; Rahl R; Lu A; Wilson CB
J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
[TBL] [Abstract][Full Text] [Related]
23. Proinflammatory cytokines remain elevated despite long-term remission in Cushing's disease: a prospective study.
Shah N; Ruiz HH; Zafar U; Post KD; Buettner C; Geer EB
Clin Endocrinol (Oxf); 2017 Jan; 86(1):68-74. PubMed ID: 27630017
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
[TBL] [Abstract][Full Text] [Related]
25. Comorbidities in Cushing's disease.
Sharma ST; Nieman LK; Feelders RA
Pituitary; 2015 Apr; 18(2):188-94. PubMed ID: 25724314
[TBL] [Abstract][Full Text] [Related]
26. Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study.
Ragnarsson O; Olsson DS; Papakokkinou E; Chantzichristos D; Dahlqvist P; Segerstedt E; Olsson T; Petersson M; Berinder K; Bensing S; Höybye C; Edén-Engström B; Burman P; Bonelli L; Follin C; Petranek D; Erfurth EM; Wahlberg J; Ekman B; Åkerman AK; Schwarcz E; Bryngelsson IL; Johannsson G
J Clin Endocrinol Metab; 2019 Jun; 104(6):2375-2384. PubMed ID: 30715394
[TBL] [Abstract][Full Text] [Related]
27. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
28. Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.
van den Bosch OF; Stades AM; Zelissen PM
Clin Endocrinol (Oxf); 2014 Feb; 80(2):184-90. PubMed ID: 23841642
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.
Wagenmakers MA; Boogaarts HD; Roerink SH; Timmers HJ; Stikkelbroeck NM; Smit JW; van Lindert EJ; Netea-Maier RT; Grotenhuis JA; Hermus AR
Eur J Endocrinol; 2013 Sep; 169(3):329-37. PubMed ID: 23786985
[TBL] [Abstract][Full Text] [Related]
30. Increased Mortality Persists after Treatment of Cushing's Disease: A Matched Nationwide Cohort Study.
Bengtsson D; Ragnarsson O; Berinder K; Dahlqvist P; Edén Engström B; Ekman B; Höybye C; Järås J; Valdemarsson S; Burman P; Wahlberg J
J Endocr Soc; 2022 Jun; 6(6):bvac045. PubMed ID: 35480633
[TBL] [Abstract][Full Text] [Related]
31. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.
Ragnarsson O; Höybye C; Jönsson PJ; Feldt-Rasmussen U; Johannsson G; Biller BM; Koltowska-Häggström M
Eur J Endocrinol; 2012 Apr; 166(4):593-600. PubMed ID: 22258111
[TBL] [Abstract][Full Text] [Related]
32. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
33. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
van der Pas R; de Bruin C; Leebeek FW; de Maat MP; Rijken DC; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; de Jong FH; van der Lely AJ; de Herder WW; Lamberts SW; Hofland LJ; Feelders RA
J Clin Endocrinol Metab; 2012 Apr; 97(4):1303-10. PubMed ID: 22278425
[TBL] [Abstract][Full Text] [Related]
34. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
35. Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
Dekkers OM; Horváth-Puhó E; Jørgensen JO; Cannegieter SC; Ehrenstein V; Vandenbroucke JP; Pereira AM; Sørensen HT
J Clin Endocrinol Metab; 2013 Jun; 98(6):2277-84. PubMed ID: 23533241
[TBL] [Abstract][Full Text] [Related]
36. Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study.
Alexandraki KI; Kaltsas GA; Isidori AM; Storr HL; Afshar F; Sabin I; Akker SA; Chew SL; Drake WM; Monson JP; Besser GM; Grossman AB
Eur J Endocrinol; 2013 Apr; 168(4):639-48. PubMed ID: 23371975
[TBL] [Abstract][Full Text] [Related]
37. Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center.
Baudry C; Coste J; Bou Khalil R; Silvera S; Guignat L; Guibourdenche J; Abbas H; Legmann P; Bertagna X; Bertherat J
Eur J Endocrinol; 2012 Oct; 167(4):473-81. PubMed ID: 22815335
[TBL] [Abstract][Full Text] [Related]
38. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study.
Clayton RN; Jones PW; Reulen RC; Stewart PM; Hassan-Smith ZK; Ntali G; Karavitaki N; Dekkers OM; Pereira AM; Bolland M; Holdaway I; Lindholm J
Lancet Diabetes Endocrinol; 2016 Jul; 4(7):569-76. PubMed ID: 27265184
[TBL] [Abstract][Full Text] [Related]
39. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
[TBL] [Abstract][Full Text] [Related]
40. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.
Johnston PC; Kennedy L; Hamrahian AH; Sandouk Z; Bena J; Hatipoglu B; Weil RJ
Pituitary; 2017 Aug; 20(4):430-440. PubMed ID: 28265841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
